Cas:7072-00-6 10-methylanthracene-9-carbaldehyde manufacturer & supplier

Chemical Name:10-methylanthracene-9-carbaldehyde

CAS.NO:7072-00-6

Synonyms:9-Formyl-10-methylanthracen;EINECS 230-366-9;9-Anthracenecarboxaldehyde,10-methyl;10-methyl-9-anthraldehyde;10-methyl-anthracene-9-carbaldehyde;10-Methylanthracen-9-carboxaldehyd;MFCD00001256;10-Methylanthracene-9-carboxyaldehyde;10-methylanthracene-9-carboxaldehyde;9-methylanthracene-10-carbaldehyde

Molecular Formula:C₁₆H₁₂O

Molecular Weight:220.26600

HS Code:2912299000

Physical and Chemical Properties:

Melting point:169-171.5ºC(lit.)

Boiling point:418.6ºC at 760 mmHg

Density:1.186g/cm3

Index of Refraction:1.722

PSA:17.07000

Exact Mass:220.08900

LogP:4.11390

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 9-Formyl-10-methylanthracen chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9-methylanthracene-10-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,10-Methylanthracene-9-carboxyaldehyde Use and application,10-methylanthracene-9-carboxaldehyde technical grade,usp/ep/jp grade.

Related News: This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy. 10-methylanthracene-9-carbaldehyde manufacturer GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. 10-methylanthracene-9-carbaldehyde supplier As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 10-methylanthracene-9-carbaldehyde vendor This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy. 10-methylanthracene-9-carbaldehyde factory As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.